A high density of galanin binding sites was found by using 1251-labeled galanin, iodinated by chloramine-T, followed by autoradiography in the ventral, but not in the dorsal, hippocampus of the rat. Lesions of the runbria and of the septum caused disappearance of a major population of these binding sites, suggesting that a large proportion of them is localized on cholinergic nerve terminals of septal afferents. Amersham. Scopolamine hydrobromide was purchased from Aldrich; physostigmine sulfate was from Sigma. All the other chemicals used were of analytical grade. Galanin antiserum was purchased from Peninsula Laboratories (San Carlos, CA). Secondary antisera were purchased from Boehringer Mannheim (Stockholm).Surgical Procedures. Four rats were anesthetized with chloral hydrate. Lesions of the dorsal hippocampal afferents were performed by the use of a retractable knife. The knife was lowered into the brain (coordinates in relation to bregma: AP, -1.4; ML, 3.0; DV, -4.0), and the blade was pushed out to the midline and retracted through the brain.Immunohistochemical, Histochemical, and Autoradiographic Analyses. Two rats were perfused through the ascending aorta with a picric acid/formalin mixture (14) for 6 min. The brains were postfixed in the same fixative, rinsed, and sectioned on a cryostat. Sections were incubated overnight at 4°C with galanin antiserum (1:400 dilution), rinsed, incubated with fluorescein isothiocyanate-conjugated secondary antibody (1:40 dilution) at 37°C for 30 min (15), rinsed, mounted, and examined with a fluorescence microscope. Some sections were processed for demonstration of AcChoE, either by the method of Karnovsky and Roots (16) or by immunohistochemistry using rabbit polyclonal antibody to AcChoE (17). For the autoradiographic analysis of 1251_ labeled galanin binding sites, the procedure of Young and Kuhar (18) was used. Briefly, pig galanin was iodinated with Na[1251] by the chloramine-T method and purified on an ion-exchange column. Rats were perfused with ice-cold Tyrode's solution, and the brain was sectioned on a cryostat, followed by incubation with 1251I-labeled galanin for 45 min at room temperature. Sections were rinsed, dried by a stream of cold air, exposed to formalin vapors, and covered by tritiumsensitive film (Ultrofilm, LKB, Stockholm). For control of nonspecific binding, unlabeled galanin (1 ,uM) was added to the incubation medium.In Vivo Experiments. In the in vivo release experiments, a thin dialysis fiber was implanted, essentially as described by Ungerstedt (19) and Benveniste et al. (20), in the hippocampi of anesthetized rats. A looped dialysis probe was implanted vertically into the ventral hippocampus of one side, while a straight dialysis probe was inserted through both dorsal hippocampi. The day after implantation, the dialysis tube was Abbreviations: AcCho, acetylcholine; AcChoE, acetylcholinesterase. §To whom reprint requests should be addressed. 7339The publication costs of this article were defrayed in part by page charge payment. This a...
Herba epimedii (HEP) is one of the most frequently used herbs prescribed for treatment of osteoporosis in China. In the present study, the in vivo effects of HEP extract on bone metabolism were evaluated using 4-month-old ovariectomized (OVX) or sham-operated (Sham) female Sprague-Dawley rats orally administered with HEP extract (110 mg kg−1d−1), 17ß-estrogen (2 mg kg−1d−1) or its vehicle for 3 months. HEP extract significantly decreased urinary calcium excretion, suppressed serum alkaline phosphatase (ALP) activity and urinary deoxypyridinoline levels in OVX rats (P < 0.05 versus vehicle-treated OVX rats). Histomorphometric analysis indicated that HEP extract could prevent OVX-induced bone loss by increasing tibial trabecular bone area and decreasing trabecular separation in OVX rats (P < 0.05 versus vehicle-treated OVX group). The in vitro effects of HEP extract were also studied using rat osteoblast-like UMR 106 cells. HEP extract significantly stimulated cell proliferation in a dose-dependent manner (P < 0.01 versus vehicle-treated) and increased ALP activity at 200 μgml−1 (P < 0.01 versus vehicle-treated) in UMR 106 cells. It modulated osteoclastogenesis by increasing osteoprotegrin (OPG) mRNA and decreasing receptor activator of NF-κB ligand (RANKL) mRNA expression, resulting in a dose-dependent increase in OPG/RANKL mRNA ratio (P < 0.01 versus vehicle-treated). Taken together, HEP treatment can effectively suppress the OVX-induced increase in bone turnover possibly by both an increase in osteoblastic activities and a decrease in osteoclastogenesis. The present study provides the evidence that HEP can be considered as a complementary and alternative medicine for treatment of post-menopausal osteoporosis.
Purpose: Mothers against decapentaplegic homologue 4 (SMAD4) is a tumor suppressor gene associated with gastrointestinal carcinogenesis. The aim of the present study is to more precisely characterize its role in the development and progression of human gastric carcinoma. Experimental Design: The expression of SMAD4 was investigated in 283 gastric adenocarcinomas and related lesions, as well as in 9 gastric carcinoma cell lines. We also analyzed the methylation status of SMAD4 gene by using methylation-specific PCR, examined loss of heterozygosity (LOH) of this gene locus by using a vicinal marker, and detected exon mutation of SMAD4 through exon-by-exon amplification. Moreover, we assessed whether MG132, a proteasome inhibitor, affected the SMAD4 protein level. Results: We found loss of SMAD4 protein expression in the cytoplasm (36 of 114, 32%) and in the nucleus (46 of 114, 40%) of gastric cancer cells. The loss of nuclear SMAD4 expression in primary tumors correlated significantly with poor survival, and was an independent prognostic marker in multivariate analysis.We also found a substantial decrease in SMAD4 expression at both the RNA and protein level in several human gastric carcinoma cell lines. In addition, we found that LOH (20 of 70, 29%) and promoter hypermethylation (4 of 73, 5%) were associated with the loss of SMAD4 expression. SMAD4 protein levels were also affected in certain gastric carcinoma cell lines following incubation with MG132. Conclusion: Taken together, our results indicate that the loss of SMAD4, especially loss of nuclear SMAD4 expression, is involved in gastric cancer progression. The loss of SMAD4 in gastric carcinomas was due to several mechanisms, including LOH, hypermethylation, and proteasome degradation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.